Latest & greatest articles for otitis media

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on otitis media or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on otitis media and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for otitis media

41. Purulent acute otitis media in adults

Purulent acute otitis media in adults Haute Autorité de Santé - Purulent acute otitis media in adults Fermer Choose language Accessibility Change contrast : Standards Reinforced icone Chercher icone plus Chercher My account My account Please fill in your email address to retrieve your email alerts subscriptions. Please fill in your email address to retrieve your newsletter subscriptions. You do not have a saved search Sélection No element in selection Services Services Déclarer un événement (...) indésirable grave Comment déclarer les EIGS Etre accrédité par la HAS Médecins exerçant une spécialité «à risques» Déposer une demande d'évaluation d'actes Modalités et procédures Organiser les soins, les parcours Coordination des soins, coopération entre professionnels Rechercher une recommandation, un guide, un médicament Rechercher une recommandation, un médicament, un guide Date : 09 November 2016 Purulent acute otitis media in adults Practice guidelines - Posted on Nov 18 2016 The aim of this memo

2016 HAS Guidelines

42. Otitis media with effusion

Otitis media with effusion Otitis media with effusion - NICE CKS Share Otitis media with effusion: Summary Otitis media with effusion (OME), also known as 'glue ear', is characterized by a collection of fluid within the middle ear space without signs of acute inflammation. OME is the most common cause of hearing impairment in childhood. The hearing loss usually resolves over several weeks or months, but may be more persistent and, if bilateral, may lead to developmental problems. Symptoms (...) of OME vary with time and the age of the child. OME is most common in young children, with the incidence highest in those aged 2 and 5 years. It presents most commonly in the winter months. The exact cause of OME is uncertain, but over 50% of cases are thought to follow an episode of acute otitis media, especially in children under 3 years of age. Persistence of OME may be caused by one or more of the following: Impaired eustachian tube function causing poor aeration of the middle ear. Low-grade

2016 NICE Clinical Knowledge Summaries

43. Purulent acute otitis media in adults

Purulent acute otitis media in adults Memo sheet Purulent acute otitis media in adults November 2016 www.has-sante.fr 5 avenue du Stade de France - 93218 Saint-Denis La Plaine CEDEX Tel.: +33(0)1 55 93 70 00 - Fax: +33(0)1 55 93 74 00 The purpose of this memo sheet is to promote the appropriate prescription of antibiotics to reduce bacterial resistance, which may lead to therapeutic impasses. The choice of antibiotic, its dose and its dosage are factors to consider for a suitable prescription

2016 HAS Guidelines

44. Purulent acute otitis media in children over 3 months

Purulent acute otitis media in children over 3 months Memo Sheet Purulent acute otitis media in children over 3 months November 2016 In case of congestive or seromucinous acute otitis media: no antibiotics. In case of purulent acute otitis media: • children 2 years with mild symptoms: no antibiotics; • children > 2 years with severe symptoms: amoxicillin, 80 or 90 mg/kg/day, for 5 days. If conjunctivitis-otitis syndrome: amoxicillin-clavulanic acid, 80 mg/kg/day, for 8-10 days

2016 HAS Guidelines

45. The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation

The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website

Full Text available with Trip Pro

2015 NIHR HTA programme

46. An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care

An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care An open randomised study of autoinflation in 4- to 11-year-old school children with otitis media with effusion in primary care Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search

2015 NIHR HTA programme

47. Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial (PubMed)

Effect of nasal balloon autoinflation in children with otitis media with effusion in primary care: an open randomized controlled trial Otitis media with effusion is a common problem that lacks an evidence-based nonsurgical treatment option. We assessed the clinical effectiveness of treatment with a nasal balloon device in a primary care setting.We conducted an open, pragmatic randomized controlled trial set in 43 family practices in the United Kingdom. Children aged 4-11 years with a recent (...) history of ear symptoms and otitis media with effusion in 1 or both ears, confirmed by tympanometry, were allocated to receive either autoinflation 3 times daily for 1-3 months plus usual care or usual care alone. Clearance of middle-ear fluid at 1 and 3 months was assessed by experts masked to allocation.Of 320 children enrolled, those receiving autoinflation were more likely than controls to have normal tympanograms at 1 month (47.3% [62/131] v. 35.6% [47/132]; adjusted relative risk [RR] 1.36, 95

Full Text available with Trip Pro

2015 EvidenceUpdates Controlled trial quality: predicted high

48. Antibiotics for acute otitis media in children. (PubMed)

Antibiotics for acute otitis media in children. Acute otitis media (AOM) is one of the most common diseases in early infancy and childhood. Antibiotic use for AOM varies from 56% in the Netherlands to 95% in the USA, Canada and Australia. This is an update of a Cochrane review first published in The Cochrane Library in Issue 1, 1997 and previously updated in 1999, 2005, 2009 and 2013.To assess the effects of antibiotics for children with AOM.We searched CENTRAL (2015, Issue 3), MEDLINE (1966 (...) of children with tympanic membrane perforations (RR 0.37, 95% CI 0.18 to 0.76; NNTB 33) and halved contralateral otitis episodes (RR 0.49, 95% CI 0.25 to 0.95; NNTB 11) compared with placebo. However, antibiotics neither reduced the number of children with abnormal tympanometry findings at three months (RR 0.97, 95% CI 0.76 to 1.24) nor the number of children with late AOM recurrences (RR 0.93, 95% CI 0.78 to 1.10) when compared with placebo. Severe complications were rare and did not differ between

Full Text available with Trip Pro

2015 Cochrane

49. Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study

Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media with effusion: a feasibility study Assessment of the feasibility and clinical value of further research to evaluate the management options for children with Down syndrome and otitis media Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you

2014 NIHR HTA programme

50. Ciloxan (Ciprofloxacin) - otitis externa or otitis media

Ciloxan (Ciprofloxacin) - otitis externa or otitis media 1/16 The legally binding text is the original French Version TRANSPARENCY COMMITTEE OPINION 19 October 2011 CILOXAN 3 mg/ml, ear drops, solution B/1 bottle of 5 ml (CIP code: 3601303) Applicant: ALCON FRANCE Ciprofloxacin ATC code: S02AA (antibiotic from the fluoroquinolone family) List I Date of Marketing Authorisation: 28 November 2002, amendment of 14 May 2008 Reason for request: Inclusion on the list of medicines refundable (...) by National Health Insurance and approved for hospital use. Medical, Economic and Public Health Assessment Division 2/16 1 CHARACTERISTICS OF THE MEDICINAL PRODUCT 1.1. Active ingredient Ciprofloxacin 1.2. Indication "Antibiotic treatment for adults and children from 1 year: - for acute otitis externa - for purulent otorrhea of the mastoid cavity and chronic suppurative otitis media with tympanic perforation. Consideration should be given to official guidance on the appropriate use of antibacterial agents

2014 Haute Autorite de sante

51. Zinc supplements for preventing otitis media. (PubMed)

Zinc supplements for preventing otitis media. Otitis media is inflammation of the middle ear and is usually caused by infection. It affects people of all ages but is particularly common in young children. Around 164 million people worldwide have long-term hearing loss caused by this condition, 90% of them in low-income countries. As zinc supplements prevent pneumonia in disadvantaged children, we wanted to investigate whether zinc supplements could also prevent otitis media.To evaluate whether (...) zinc supplements prevent otitis media in adults and children of different ages.We searched CENTRAL (2014, Issue 1), MEDLINE (1950 to February week 4, 2014) and EMBASE (1974 to March 2014).Randomised, placebo-controlled trials of zinc supplements given at least once a week for at least a month for preventing otitis media.Two review authors independently assessed the eligibility and methodological quality of the included trials and extracted and analysed data. We summarised results using risk ratios

Full Text available with Trip Pro

2014 Cochrane

52. Pneumococcal conjugate vaccines for preventing otitis media. (PubMed)

Pneumococcal conjugate vaccines for preventing otitis media. Acute otitis media (AOM) is a very common respiratory infection in early infancy and childhood. The marginal benefits of antibiotics for AOM in low-risk populations in general, the increasing problem of bacterial resistance to antibiotics and the huge estimated direct and indirect annual costs associated with otitis media (OM) have prompted a search for effective vaccines to prevent AOM.To assess the effect of pneumococcal conjugate

Full Text available with Trip Pro

2014 Cochrane

53. Xylitol syrup for the prevention of acute otitis media (PubMed)

Xylitol syrup for the prevention of acute otitis media Acute otitis media (AOM) is a common childhood illness and the leading indication for antibiotic prescriptions for US children. Xylitol, a naturally occurring sugar alcohol, can reduce AOM when given 5 times per day as a gum or syrup, but a more convenient dosing regimen is needed for widespread adoption.We designed a pragmatic practice-based randomized controlled trial to determine if viscous xylitol solution at a dose of 5 g 3 times per (...) day could reduce the occurrence of clinically diagnosed AOM among otitis-prone children 6 months through 5 years of age.A total of 326 subjects were enrolled, with 160 allocated to xylitol and 166 to placebo. In the primary analysis of time to first clinically diagnosed AOM episode, the hazard ratio for xylitol versus placebo recipients was 0.88 (95% confidence interval [CI] 0.61 to 1.3). In secondary analyses, the incidence of AOM was 0.53 episodes per 90 days in the xylitol group versus 0.59

Full Text available with Trip Pro

2014 EvidenceUpdates Controlled trial quality: predicted high

54. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis.

Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information

2014 NIHR HTA programme

55. Systematic review and meta-analysis: Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media

Systematic review and meta-analysis: Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Oral antibiotics confer small benefits and small harms in low-risk children with acute otitis media Article Text Therapeutics Systematic review and meta

2014 Evidence-Based Medicine (Requires free registration)

57. Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis

Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis Adenoidectomy with or without grommets for children with otitis media: an individual patient data meta-analysis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information

2014 NIHR HTA programme

58. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. (PubMed)

Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. Acute otitis media (AOM) is a common problem in children, for which amoxicillin, with or without clavulanate, is frequently prescribed as a treatment of choice. The conventional recommendation is either three or four daily doses. However, nowadays it is frequently prescribed as once or twice daily doses. If once or twice daily amoxicillin, with or without clavulanate (...) , is as effective for acute otitis media as three or four times a day, it may be more convenient to give the medication once or twice a day to children and hence improve compliance.To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children; and to compare complication rates and adverse reactions.We searched CENTRAL 2013, Issue 2, MEDLINE (January 1950 to March week 1, 2013), EMBASE (1974 to March 2013

Full Text available with Trip Pro

2013 Cochrane

59. Otitis media with effusion: comparative effectiveness of treatments

Otitis media with effusion: comparative effectiveness of treatments Otitis media with effusion: comparative effectiveness of treatments Otitis media with effusion: comparative effectiveness of treatments Berkman ND, Wallace IF, Steiner MJ, Harrison M, Greenblatt AM, Lohr KN, Kimple A, Yuen A Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) Berkman ND, Wallace IF, Steiner MJ, Harrison M, Greenblatt AM, Lohr KN, Kimple A, Yuen A. Otitis media with effusion: comparative effectiveness of treatments. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 101. 2013 Authors' objectives To compare benefits and harms of strategies currently in use for managing otitis media with effusion (OME). Treatment for OME may include single approaches alone or combinations of two or more approaches. We compared

2013 Health Technology Assessment (HTA) Database.

60. Diagnosis and Management of Acute Otitis Media

Diagnosis and Management of Acute Otitis Media The Diagnosis and Management of Acute Otitis Media | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search for this keyword Source User menu Sections Sign up for highlighting editor-chosen studies with the greatest impact on clinical care. The Diagnosis and Management of Acute Otitis (...) Media Allan S. Lieberthal , Aaron E. Carroll , Tasnee Chonmaitree , Theodore G. Ganiats , Alejandro Hoberman , Mary Anne Jackson , Mark D. Joffe , Donald T. Miller , Richard M. Rosenfeld , Xavier D. Sevilla , Richard H. Schwartz , Pauline A. Thomas , David E. Tunkel This article has a correction. Please see: Abstract This evidence-based clinical practice guideline is a revision of the 2004 acute otitis media (AOM) guideline from the American Academy of Pediatrics (AAP) and American Academy of Family

2013 American Academy of Family Physicians